Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 37.35p
   
  • Change Today:
      0.000p
  • 52 Week High: 65.00
  • 52 Week Low: 25.50
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 300
  • Market Cap: £112.59m
  • RiskGrade: 479

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
67.15% above the market average67.15% above the market average67.15% above the market average67.15% above the market average67.15% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average
Price Book Ratio
97.11% below the market average97.11% below the market average97.11% below the market average97.11% below the market average97.11% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
11.12% above the market average11.12% above the market average11.12% above the market average11.12% above the market average11.12% above the market average
Sector averageSector averageSector averageSector averageSector average
Price Chg 3m
65.12% below the market average65.12% below the market average65.12% below the market average65.12% below the market average65.12% below the market average
25.93% below the sector average25.93% below the sector average25.93% below the sector average25.93% below the sector average25.93% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
39.60% above the market average39.60% above the market average39.60% above the market average39.60% above the market average39.60% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
Momentum 20
25.73% above the market average25.73% above the market average25.73% above the market average25.73% above the market average25.73% above the market average
44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
80.35% below the market average80.35% below the market average80.35% below the market average80.35% below the market average80.35% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
62.23% below the market average62.23% below the market average62.23% below the market average62.23% below the market average62.23% below the market average
13.73% below the sector average13.73% below the sector average13.73% below the sector average13.73% below the sector average13.73% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
61.69% below the market average61.69% below the market average61.69% below the market average61.69% below the market average61.69% below the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average
Operating Profit Loss
76.52% below the market average76.52% below the market average76.52% below the market average76.52% below the market average76.52% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.22% below the market average35.22% below the market average35.22% below the market average35.22% below the market average35.22% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Cash
1.68% below the market average1.68% below the market average1.68% below the market average1.68% below the market average1.68% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.79% above the market average65.79% above the market average65.79% above the market average65.79% above the market average65.79% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 37.35p
Change Today 0.000p
% Change 0.00 %
52 Week High 65.00
52 Week Low 25.50
Volume 300
Shares Issued 301.45m
Market Cap £112.59m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
48.32% below the market average48.32% below the market average48.32% below the market average48.32% below the market average48.32% below the market average
17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average17.65% below the sector average
Price Trend
37.09% above the market average37.09% above the market average37.09% above the market average37.09% above the market average37.09% above the market average
62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average62.96% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 04-Jun-2024

Time Volume / Share Price
08:00 300 @ 37.95p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page